TEST BANK FOR
ll ll
PHARMACOLOGYFOR
ll l
PRIMARYPROVIDER
ll l
4TH EDITION
ll ll
EDMUNDS
ll
,Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs.
ll ll ll ll ll ll ll ll
Change
ll Test Bank
l l ll
MULTIPLE llCHOICE
1. Which llof llthe llfollowing llhas llinfluenced llan llemphasis llon llprimary llcare lleducation llin
medical
ll l l schools?
a. Changes llin llMedicare llreimbursement
l l methods llrecommended llin ll1992
b. Competition lfrom lnonphysicians ldesiring
l l to llmeet llprimary llcare llshortages
c. The llneed llfor llmonopolistic llcontrol llin
llthe l l marketplace llof llprimary lloutpatient
llcare
d. The llrecognition llthat llnonphysicians llhave
ll variable llsuccess llproviding llprimary
llcare
ANS: l l A
The llPhysician llPayment llReview llCommission llin ll1992 lldirectly llincreased llfinancial
l l reimbursement llto llclinicians llwho llprovide llprimary llcare. llCoupled llwith lla llshortage llof
l l primary llcare llproviders, llthis llincentive llled llmedical llschools llto llplace llgreater llemphasis
llon l l preparing llprimary llcare llphysicians. llCompetition llfrom llnonphysicians llincreased
l l coincidentally llas llprofessionals llfrom llother lldisciplines llstepped llup llto llmeet llthe llneeds.
Nonphysicians llhave llhad llincreasing llsuccess llat llproviding llprimary llcare lland llhave llbeen
l l shown llto llbe llsafe lland lleffective.
DIF: Cognitive llLevel: llRemembering ll(Knowledge) REF: ll ll2
2. Which llof llthe llfollowing llstatements llis lltrue llabout llthe llprescribing llpractices llof llphysicians?
a. Older llphysicians lltend llto llprescribe
llmore l l appropriate llmedications llthan
llyounger l l physicians.
b. Antibiotic llmedications llremain llin llthe
lltop l l five llclassifications llof llmedications
l l prescribed.
c. Most llphysicians llrely llon lla ll“therapeutic
l l armamentarium” llthat llconsists llof llless
llthan l l 100 lldrug llpreparations llper
llphysician.
d. The lldominant llform llof lldrug llinformation
l lused llby llprimary llcare llphysicians
llcontinues l l to llbe llthat llprovided llby
llpharmaceutical l l companies.
ANS: l l D
Even llthough llmost llphysicians llclaim llto llplace lllittle llweight llon lldrug lladvertisements,
1
, pharmaceutical llrepresentatives, lland llpatient llpreference lland llstate llthat llthey llrely llon
l l academic llsources llfor lldrug llinformation, lla llstudy llshowed llthat llcommercial llrather llthan
l l scientific llsources llof lldrug llinformation lldominated lltheir lldrug llinformation llmaterials.
l l Younger llphysicians lltend llto llprescribe llfewer lland llmore llappropriate lldrugs. lAntibiotics
llhave l l dropped llout llof llthe lltop llfive llclassifications llof lldrugs llprescribed. llMost
llphysicians llhave lla l l therapeutic llarmamentarium llof llabout ll144 lldrugs.
DIF: Cognitive llLevel: llRemembering ll(Knowledge) REF: ll ll3
3. As llprimary llcare llnurse llpractitioners ll(NPs) llcontinue llto lldevelop lltheir llrole llas
ll prescribers llof l l medications, llit llwill llbe llimportant llto:
a. attain llthe llsame lllevel llof llexpertise
llas l l physicians l l who l l currently
l l prescribe l l medications.
b. learn llfrom llthe llexperiences llof llphysicians
l l and lldevelop llexpertise llbased llon
llevidence- l l based llpractice.
c. maintain llcollaborative lland
llsupervisorial l l relationships llwith
llphysicians llwho llwill l l oversee
llprescribing llpractices.
d. develop lrelationships llwith lpharmaceutical
l l representatives llto lllearn llabout llnew
l l medications llas llthey llare lldeveloped.
ANS: l l B
As llnonphysicians lldevelop llthe llroles llassociated llwith llprescriptive llauthority, llit llwill llbe
l l important llto lllearn llfrom llthe llpast llexperiences llof llphysicians lland llto lldevelop
llprescribing l l practices llbased llon llevidence-based llmedicine. llIt llis llhoped llthat llall
llprescribers, llincluding l l physicians lland llnurse llpractitioners, llwill llstrive llto lldo llbetter
llthan llin llthe llpast. llNPs llshould l l work lltoward llprescriptive llauthority lland llfor llpractice
llthat llis llnot llsupervised llby llanother l l professional. llPharmaceutical llrepresentatives
llprovide llinformation llthat llcarries llsome llbias. l l Academic llsources llare llbetter.
DIF: Cognitive llLevel: llApplying ll(Application) REF: ll ll4
Chapter 02: Historical Review of Prescriptive Authority: The Role of Nurses (NPs,
l ll ll ll ll l ll ll ll ll ll
CNMs, CRNAs, and CNSs) and Physician Assistants
ll ll ll ll ll ll l
Test Bank
l
MULTIPLE llCHOICE
1. A llprimary llcare llNP llwill llbegin llpracticing llin lla llstate llin llwhich llthe llgovernor llhas llopted
llout llof l l the llfederal llfacility llreimbursement llrequirement. llThe llNP llshould llbe llaware
llthat llthis lldefines l l how llNPs llmay llwrite llprescriptions:
2
, a. without llphysician llsupervision llin llprivate
l l practice.
b. as llCRNAs llwithout llphysician llsupervision
l l in lla llhospital llsetting.
c. in llany llsituation llbut llwill llnot llbe
llreimbursed l l for llthis llby llgovernment
llinsurers.
d. only llwith llphysician llsupervision llin
llboth l l private llpractice lland lla llhospital
llsetting.
ANS: l l B
In ll2001, llthe llCenters llfor llMedicare lland llMedicaid llServices llchanged llthe llfederal
llphysician l l supervision llrule llfor llCRNAs llto llallow llstate llgovernors llto llopt llout,
llallowing llCRNAs llto llwrite l l prescriptions lland lldispense lldrugs llwithout llphysician
llsupervision.
DIF: Cognitive llLevel: llUnderstanding ll(Comprehension) REF: ll ll9
2. CRNAs llin llmost llstates:
a. must llhave lla llDrug llEnforcement
l l Administration ll(DEA) llnumber llto
llpractice.
b. must llhave llprescriptive llauthority
llto l l practice.
c. order lland lladminister llcontrolled llsubstances
l l but lldo llnot llhave llfull llprescriptive
llauthority.
d. administer llmedications, llincluding
l l controlled llsubstances, llunder
lldirect l l physician lsupervision.
ANS: l l C
Only llfive llstates llgrant llindependent llprescriptive llauthority llto llCRNAs. llCRNAs lldo llnot
l l require llprescriptive llauthority llbecause llthey lldispense lla lldrug llimmediately llto lla llpatient
lland l l do llnot llprescribe. llWithout llprescriptive llauthority, llthey lldo llnot llneed lla llDEA
lnumber.
DIF: Cognitive llLevel: llUnderstanding ll(Comprehension) REF: ll ll9
3. A lCNM:
a. may lltreat llonly llwomen.
b. has llprescriptive llauthority llin llall ll50 llstates.
c. may lladminister llonly lldrugs llused
llduring l l labor lland lldelivery.
d. may llpractice llonly llin llbirthing llcenters
lland l l home llbirth llsettings.
ANS: l l B
ll ll
PHARMACOLOGYFOR
ll l
PRIMARYPROVIDER
ll l
4TH EDITION
ll ll
EDMUNDS
ll
,Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs.
ll ll ll ll ll ll ll ll
Change
ll Test Bank
l l ll
MULTIPLE llCHOICE
1. Which llof llthe llfollowing llhas llinfluenced llan llemphasis llon llprimary llcare lleducation llin
medical
ll l l schools?
a. Changes llin llMedicare llreimbursement
l l methods llrecommended llin ll1992
b. Competition lfrom lnonphysicians ldesiring
l l to llmeet llprimary llcare llshortages
c. The llneed llfor llmonopolistic llcontrol llin
llthe l l marketplace llof llprimary lloutpatient
llcare
d. The llrecognition llthat llnonphysicians llhave
ll variable llsuccess llproviding llprimary
llcare
ANS: l l A
The llPhysician llPayment llReview llCommission llin ll1992 lldirectly llincreased llfinancial
l l reimbursement llto llclinicians llwho llprovide llprimary llcare. llCoupled llwith lla llshortage llof
l l primary llcare llproviders, llthis llincentive llled llmedical llschools llto llplace llgreater llemphasis
llon l l preparing llprimary llcare llphysicians. llCompetition llfrom llnonphysicians llincreased
l l coincidentally llas llprofessionals llfrom llother lldisciplines llstepped llup llto llmeet llthe llneeds.
Nonphysicians llhave llhad llincreasing llsuccess llat llproviding llprimary llcare lland llhave llbeen
l l shown llto llbe llsafe lland lleffective.
DIF: Cognitive llLevel: llRemembering ll(Knowledge) REF: ll ll2
2. Which llof llthe llfollowing llstatements llis lltrue llabout llthe llprescribing llpractices llof llphysicians?
a. Older llphysicians lltend llto llprescribe
llmore l l appropriate llmedications llthan
llyounger l l physicians.
b. Antibiotic llmedications llremain llin llthe
lltop l l five llclassifications llof llmedications
l l prescribed.
c. Most llphysicians llrely llon lla ll“therapeutic
l l armamentarium” llthat llconsists llof llless
llthan l l 100 lldrug llpreparations llper
llphysician.
d. The lldominant llform llof lldrug llinformation
l lused llby llprimary llcare llphysicians
llcontinues l l to llbe llthat llprovided llby
llpharmaceutical l l companies.
ANS: l l D
Even llthough llmost llphysicians llclaim llto llplace lllittle llweight llon lldrug lladvertisements,
1
, pharmaceutical llrepresentatives, lland llpatient llpreference lland llstate llthat llthey llrely llon
l l academic llsources llfor lldrug llinformation, lla llstudy llshowed llthat llcommercial llrather llthan
l l scientific llsources llof lldrug llinformation lldominated lltheir lldrug llinformation llmaterials.
l l Younger llphysicians lltend llto llprescribe llfewer lland llmore llappropriate lldrugs. lAntibiotics
llhave l l dropped llout llof llthe lltop llfive llclassifications llof lldrugs llprescribed. llMost
llphysicians llhave lla l l therapeutic llarmamentarium llof llabout ll144 lldrugs.
DIF: Cognitive llLevel: llRemembering ll(Knowledge) REF: ll ll3
3. As llprimary llcare llnurse llpractitioners ll(NPs) llcontinue llto lldevelop lltheir llrole llas
ll prescribers llof l l medications, llit llwill llbe llimportant llto:
a. attain llthe llsame lllevel llof llexpertise
llas l l physicians l l who l l currently
l l prescribe l l medications.
b. learn llfrom llthe llexperiences llof llphysicians
l l and lldevelop llexpertise llbased llon
llevidence- l l based llpractice.
c. maintain llcollaborative lland
llsupervisorial l l relationships llwith
llphysicians llwho llwill l l oversee
llprescribing llpractices.
d. develop lrelationships llwith lpharmaceutical
l l representatives llto lllearn llabout llnew
l l medications llas llthey llare lldeveloped.
ANS: l l B
As llnonphysicians lldevelop llthe llroles llassociated llwith llprescriptive llauthority, llit llwill llbe
l l important llto lllearn llfrom llthe llpast llexperiences llof llphysicians lland llto lldevelop
llprescribing l l practices llbased llon llevidence-based llmedicine. llIt llis llhoped llthat llall
llprescribers, llincluding l l physicians lland llnurse llpractitioners, llwill llstrive llto lldo llbetter
llthan llin llthe llpast. llNPs llshould l l work lltoward llprescriptive llauthority lland llfor llpractice
llthat llis llnot llsupervised llby llanother l l professional. llPharmaceutical llrepresentatives
llprovide llinformation llthat llcarries llsome llbias. l l Academic llsources llare llbetter.
DIF: Cognitive llLevel: llApplying ll(Application) REF: ll ll4
Chapter 02: Historical Review of Prescriptive Authority: The Role of Nurses (NPs,
l ll ll ll ll l ll ll ll ll ll
CNMs, CRNAs, and CNSs) and Physician Assistants
ll ll ll ll ll ll l
Test Bank
l
MULTIPLE llCHOICE
1. A llprimary llcare llNP llwill llbegin llpracticing llin lla llstate llin llwhich llthe llgovernor llhas llopted
llout llof l l the llfederal llfacility llreimbursement llrequirement. llThe llNP llshould llbe llaware
llthat llthis lldefines l l how llNPs llmay llwrite llprescriptions:
2
, a. without llphysician llsupervision llin llprivate
l l practice.
b. as llCRNAs llwithout llphysician llsupervision
l l in lla llhospital llsetting.
c. in llany llsituation llbut llwill llnot llbe
llreimbursed l l for llthis llby llgovernment
llinsurers.
d. only llwith llphysician llsupervision llin
llboth l l private llpractice lland lla llhospital
llsetting.
ANS: l l B
In ll2001, llthe llCenters llfor llMedicare lland llMedicaid llServices llchanged llthe llfederal
llphysician l l supervision llrule llfor llCRNAs llto llallow llstate llgovernors llto llopt llout,
llallowing llCRNAs llto llwrite l l prescriptions lland lldispense lldrugs llwithout llphysician
llsupervision.
DIF: Cognitive llLevel: llUnderstanding ll(Comprehension) REF: ll ll9
2. CRNAs llin llmost llstates:
a. must llhave lla llDrug llEnforcement
l l Administration ll(DEA) llnumber llto
llpractice.
b. must llhave llprescriptive llauthority
llto l l practice.
c. order lland lladminister llcontrolled llsubstances
l l but lldo llnot llhave llfull llprescriptive
llauthority.
d. administer llmedications, llincluding
l l controlled llsubstances, llunder
lldirect l l physician lsupervision.
ANS: l l C
Only llfive llstates llgrant llindependent llprescriptive llauthority llto llCRNAs. llCRNAs lldo llnot
l l require llprescriptive llauthority llbecause llthey lldispense lla lldrug llimmediately llto lla llpatient
lland l l do llnot llprescribe. llWithout llprescriptive llauthority, llthey lldo llnot llneed lla llDEA
lnumber.
DIF: Cognitive llLevel: llUnderstanding ll(Comprehension) REF: ll ll9
3. A lCNM:
a. may lltreat llonly llwomen.
b. has llprescriptive llauthority llin llall ll50 llstates.
c. may lladminister llonly lldrugs llused
llduring l l labor lland lldelivery.
d. may llpractice llonly llin llbirthing llcenters
lland l l home llbirth llsettings.
ANS: l l B
